Carboxamide compounds and their use as calpain inhibitors

Details for Australian Patent Application No. 2010334915 (hide)

Owner Abbott Laboratories Abbott GmbH & Co. KG

Inventors Kling, Andreas; Jantos, Katja; Mack, Helmut; Moller, Achim; Hornberger, Wilfried; Backfisch, Gisela; Lao, Yanbin; Nijsen, Marjoleen

Agent Spruson & Ferguson

Pub. Number AU-A-2010334915

PCT Pub. Number WO2011/076811

Priority 61/410,414 05.11.10 US; 61/288,935 22.12.09 US

Filing date 21 December 2010

Wipo publication date 30 June 2011

International Classifications

C07D 207/28 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4015 - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/4439

A61P 9/00 Drugs for disorders of the cardiovascular system

A61P 13/12 Drugs for disorders of the urinary system

A61P 21/00 Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 Drugs for disorders of the nervous system

A61P 25/28 Drugs for disorders of the nervous system

A61P 27/08 Drugs for disorders of the senses

A61P 31/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 Antineoplastic agents

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/076811 Priority application(s): WO2011/076811

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010334918-Predictive value of IL28b gene polymorphism combined with pretreatment serum IP-10 quantification for response to peginterferon and ribavirin is enhanced in comparison with any of these biomarkers alone

2010334911-Lipids, lipid compositions, and methods of using them